Reckitt Benckiser Group plc (RBGPF) Stock Price & Analysis
Reckitt Benckiser Group plc (RBGPF) — price $75.30 (-0.46%), as of the Nov 19, 2026 trading session; market cap $47.7B.
Educational signal · not a buy or sell recommendation · How to read this
Reckitt Benckiser Group plc · RBGPF · Consumer Defensive · Household & Personal Products
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen,…
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $75.30 | |
| Change on the day | -0.46% | |
| 52-week range | $58.67–$90.71 | |
| Market capitalisation | $47.7B | — |
| Price / earnings (trailing) | 12.87 | |
| Shares traded on the day | 12 | |
| Beta (volatility vs the S&P 500) | 0.26 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for Reckitt Benckiser Group (RBGPF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
4 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 8, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Apr 29, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Apr 29, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Reckitt Benckiser Group (RBGPF), and what does it report?
Short answer
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen,… Reckitt Benckiser Group plc (RBGPF) is classified as Consumer Defensive / Household & Personal Products. SEC filing business address: 103-105 Bath Road, Slough, X0, SL1 3UH. It employs 36,200 people and is led by Kris Licht. In Q2 FY2026 it reported revenue of £6.36B and net income of £647M. The market values it at $47.7B.
What do the latest results show for Reckitt Benckiser Group (RBGPF)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of £6.36B. Against analyst estimates the company has EPS beat 3 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | £6.36B | £647M | £1.00 (diluted) |
| Q4 FY2025 | £7.22B | £2.22B | £3.41 (diluted) |
| Q2 FY2025 | £6.98B | £958M | £1.41 (diluted) |
| Q4 FY2024 | £7.00B | £284M | £0.40 (diluted) |
What are the financial strengths and risks for Reckitt Benckiser Group (RBGPF)?
Short answer · as of
The distress and quality screens read Altman Z 2.50 · Piotroski F 5. Trailing ratios: ROE 48.0% · ROA 7.9% · current ratio 0.59.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held RBGPF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported RBGPF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Reckitt Benckiser Group Consumer Defensive Stock: Key Questions Answered
These answers are editorial: 1 of these 8 answers is drawn from the RBGPF research dossier (written Jun 14, 2026 by gpt-4o-mini); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is RBGPF a good stock to buy?
Stock Expert AI does not rate RBGPF buy, sell or hold. Reckitt Benckiser Group plc has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the RBGPF stock price today?
The last price recorded for Reckitt Benckiser Group plc (RBGPF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does Reckitt Benckiser Group plc do?
Reckitt Benckiser Group plc manufactures and sells a wide range of health, hygiene, and nutrition products. The company offers various items including personal care products, household cleaning solutions, and nutritional supplements under well-known brands such as Dettol, Durex, and Gaviscon.
What are the key factors to evaluate for RBGPF?
Evaluate RBGPF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Innovation in Product Development: The company is focusing on innovation to meet changing consumer preferences, particularly in health and nutrition. Not financial advice.
How frequently does RBGPF data refresh on this page?
RBGPF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven RBGPF's recent stock price performance?
Reckitt Benckiser Group plc (RBGPF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand portfolio with high consumer loyalty. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RBGPF overvalued or undervalued right now?
The trailing P/E of Reckitt Benckiser Group plc (RBGPF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research RBGPF before investing?
Before investing in Reckitt Benckiser Group plc (RBGPF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 19 figures on this page — 1 from SEC filings and earnings calls, 15 from Financial Modeling Prep (FMP) and 3 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com